✦ LIBER ✦

Antiparkinsonian activity of talipexole in MPTP-treated monkeys: in combination with L-DOPA and as chronic treatment

✍ Scribed by Masahiro Irifune; Masahiro Nomoto; Takeo Fukuda

Book ID: 115889089
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 636 KB
Volume: 264
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(94)00446-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined effects of cabergoline and L-do

Combined effects of cabergoline and L-dopa on parkinsonism in MPTP-treated cynomolgus monkeys

✍ N. Arai; M. Isaji; M. Kojima; E. Mizuta; S. Kuno 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 524 KB

Antiparkinsonian activity and dyskinesia

Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naive MPTP-lesioned common marmosets (Callithrix jacchus)

✍ Eleni C. Maratos; Michael J. Jackson; Ronald K. B. Pearce; Peter Jenner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Abstract De novo administration of long‐acting dopamine agonists, such as ropinirole, to patients with Parkinson's disease or to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐treated subhuman primates produces a lower incidence of dyskinesia than occurs with L‐DOPA. This study compares the

Combined Use of the Adenosine A2A Antago

Combined Use of the Adenosine A2A Antagonist KW-6002 with l-DOPA or with Selective D1 or D2 Dopamine Agonists Increases Antiparkinsonian Activity but Not Dyskinesia in MPTP-Treated Monkeys

✍ Tomoyuki Kanda; Michael J. Jackson; Lance A. Smith; Ronald K.B. Pearce; Joji Nak 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Expression of GAD65 and GAD67 immunoreac

Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without l-DOPA administration

✍ Diane T. Stephenson; Qiu Li; Carol Simmons; Mark A. Connell; Martin D. Meglasson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 886 KB

Nicotine Alone and in Combination with l

Nicotine Alone and in Combination with l-DOPA Methyl Ester or the D2 Agonist N-0923 in MPTP-Induced Chronic Hemiparkinsonian Monkeys

✍ Edward F. Domino; Lisong Ni; Huilei Zhang 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 242 KB

3-30-17 Combined effects of long-acting

3-30-17 Combined effects of long-acting D2 agonist, cabergoline and L-DOPA on parkinsonism in MPTP-treated cynomolgus monkeys

✍ S. Kuno; E. Mizuta; N. Arai; M. Isaji; A. Ujiie 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 173 KB